GX
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GX, covering 2024-01-22 to 2024-05-10. Get the full timeline:
Most recent: Clinical Trial Update: Nimotuzumab Combined With GX as Postoperative Adjuvant Therapy in Pancreatic Cancer [Phase 2, Phase 3]